EDMA, or 3,4-ethylenedioxy-N-methylamphetamine, is a lesser-known psychedelic drug and a substituted amphetamine. EDMA was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 200mg, and the duration listed as 3-5 hours. EDMA produces hypnogogic imagery and empathogenic, non-psychedelic MDMA-like effects. It generally has a threshold, and no other effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of EDMA.
EDMA AND EUCOMED JOIN FORCES.(European Diagnostic Manufacturers Association)(European medical technology industry association)(Brief article)
Jan 24, 2012; The European Diagnostic Manufacturers Association (EDMA) and the European medical technology industry association...